These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1207 related articles for article (PubMed ID: 27520808)

  • 1. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
    Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
    Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability.
    Duarte A; Ferreira S; Almeida S; Domingues FC
    Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance.
    Lin MF; Lin YY; Tu CC; Lan CY
    J Microbiol Immunol Infect; 2017 Apr; 50(2):224-231. PubMed ID: 26055688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting Colistin Resistance Mechanisms in Extensively Drug-Resistant Acinetobacter baumannii Clinical Isolates.
    Trebosc V; Gartenmann S; Tötzl M; Lucchini V; Schellhorn B; Pieren M; Lociuro S; Gitzinger M; Tigges M; Bumann D; Kemmer C
    mBio; 2019 Jul; 10(4):. PubMed ID: 31311879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of antibiotic resistance and sequence type of Acinetobacter baumannii clinical isolates in Japan and the antibacterial activity of DS-8587.
    Higuchi S; Shikata M; Chiba M; Hoshino K; Gotoh N
    J Infect Chemother; 2014 Apr; 20(4):256-61. PubMed ID: 24709045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates.
    Bardbari AM; Arabestani MR; Karami M; Keramat F; Alikhani MY; Bagheri KP
    Microb Pathog; 2017 Jul; 108():122-128. PubMed ID: 28457900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii.
    Godeux AS; Lupo A; Haenni M; Guette-Marquet S; Wilharm G; Laaberki MH; Charpentier X
    J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30012729
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.
    Warner WA; Kuang SN; Hernandez R; Chong MC; Ewing PJ; Fleischer J; Meng J; Chu S; Terashita D; English L; Chen W; Xu HH
    BMC Infect Dis; 2016 May; 16():194. PubMed ID: 27146090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistant mechanisms and molecular epidemiology of imipenem-resistant Acinetobacter baumannii.
    Xiao SZ; Chu HQ; Han LZ; Zhang ZM; Li B; Zhao L; Xu L
    Mol Med Rep; 2016 Sep; 14(3):2483-8. PubMed ID: 27485638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
    Farzi N; Oloomi M; Bahramali G; Siadat SD; Bouzari S
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of genotypically and phenotypically diverse clinical
    Sun C; Zhou D; He J; Liu H; Fu Y; Zhou Z; Leptihn S; Yu Y; Hua X; Xu Q
    Microbiol Spectr; 2024 Aug; 12(8):e0008624. PubMed ID: 38916336
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.
    Zavascki AP; Carvalhaes CG; Picão RC; Gales AC
    Expert Rev Anti Infect Ther; 2010 Jan; 8(1):71-93. PubMed ID: 20014903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
    Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
    Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and phenotypic analyses of multidrug-resistant
    Kim M; Park J; Park W
    Virulence; 2021 Dec; 12(1):150-164. PubMed ID: 33372826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial action of 1,10-phenanthroline-based compounds on carbapenemase-producing Acinetobacter baumannii clinical strains: efficacy against planktonic- and biofilm-growing cells.
    Ventura RF; Galdino ACM; Viganor L; Schuenck RP; Devereux M; McCann M; Santos ALS; Nunes APF
    Braz J Microbiol; 2020 Dec; 51(4):1703-1710. PubMed ID: 32737867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis reveals high virulence and antibiotic resistance amongst phage susceptible Acinetobacter baumannii.
    Leungtongkam U; Thummeepak R; Kitti T; Tasanapak K; Wongwigkarn J; Styles KM; Wellington EMH; Millard AD; Sagona AP; Sitthisak S
    Sci Rep; 2020 Sep; 10(1):16154. PubMed ID: 32999368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital.
    Elabd FM; Al-Ayed MS; Asaad AM; Alsareii SA; Qureshi MA; Musa HA
    J Infect Public Health; 2015; 8(3):242-7. PubMed ID: 25466594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.